Although ApoA-I is linked to the development of various tumors and is a potential biochemical marker for diagnosing various cancers (27, 28), limited research has explored the correlation between ApoA-I level and the outcomes of patients with CRC. This evidence concerns the gene APOA1 and colorectal carcinoma.